Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Subjects
More information
Scope and Contents
Contents
ObjectiveTo determine the harms of proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors in people who need lipid-lowering therapy.MethodsThis systematic review included randomised controlled trials that compared PCSK9 inhibitors with placebo, standard care or active lipid-lowering comparators in people who need lipid-lowering therapy with th...
Alternative Titles
Full title
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2660103452
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2660103452
Other Identifiers
ISSN
1355-6037,1468-201X
E-ISSN
1468-201X
DOI
10.1136/heartjnl-2021-320556
